- Home
- Publications
- Publication Search
- Publication Details
Title
Early prediction of tumour response to PRRT
Authors
Keywords
-
Journal
NUKLEARMEDIZIN-NUCLEAR MEDICINE
Volume 52, Issue 5, Pages 170-177
Publisher
Schattauer GmbH
Online
2013-08-21
DOI
10.3413/nukmed-0581-13-05
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Significant impact of transient deterioration of renal function on dosimetry in PRRT
- (2012) Sofie Van Binnebeek et al. ANNALS OF NUCLEAR MEDICINE
- Three-dimensional radiobiological dosimetry of kidneys for treatment planning in peptide receptor radionuclide therapy
- (2012) Sébastien Baechler et al. MEDICAL PHYSICS
- Minor changes in effective half-life during fractionated177Lu-Octreotate therapy
- (2011) Ulrike Garske et al. ACTA ONCOLOGICA
- 177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy
- (2010) Michael Garkavij et al. CANCER
- Renal Dosimetry
- (2010) Barry W. Wessels et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Impact of the Ki-67 proliferation index on response to peptide receptor radionuclide therapy
- (2010) Samer Ezziddin et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-DOTATATE PET/CT for the Early Prediction of Response to Somatostatin Receptor-Mediated Radionuclide Therapy in Patients with Well-Differentiated Neuroendocrine Tumors
- (2010) A. R. Haug et al. JOURNAL OF NUCLEAR MEDICINE
- Defining Pharmacokinetics for Individual Patient Dosimetry in Routine Radiopeptide and Radioimmunotherapy of Cancer: Australian Experience
- (2009) J. Turner CURRENT PHARMACEUTICAL DESIGN
- Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
- (2009) Dik J Kwekkeboom et al. ENDOCRINE-RELATED CANCER
- Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate
- (2009) Flavio Forrer et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Individualized dosimetry in patients undergoing therapy with 177Lu-DOTA-D-Phe1-Tyr3-octreotate
- (2009) Mattias Sandström et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma
- (2009) Sara Gonias et al. JOURNAL OF CLINICAL ONCOLOGY
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogs
- (2009) Dik J. Kwekkeboom et al. NEUROENDOCRINOLOGY
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started